glutathione and triple negative breast cancer Role of in Cancer: From Mechanisms to Therapies Activation of the eIF2α/ATF4 axis
Activation of the eIF2 ATF4 axis drives triple negative breast cancer radioresistance by promoting glutathione biosynthesis ScienceDirect A review of biological targets and therapeutic approaches in the management of triple negative breast cancer ScienceDirect Glutathione: Lights and Shadows in Cancer Patients PMC GPX4 in triple negative breast cancer: A key regulator of ferroptosis and therapeutic target ScienceDirect Dual metabolic targeting liposomes potentiate triple negative breast cancer radiosensitivity via glucose and glutathione starvation ScienceDirect
Pay in 4 interest-free payments of $6.89 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




